Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Itera-Ethanol was a specialized subsidiary of the Itera Group, a major Russian energy company, focused on the development and production of bioethanol. Established in the mid-2000s, the company aimed to build large-scale industrial biotechnology facilities to convert grain into fuel-grade ethanol, with a flagship project planned in the Sverdlovsk region. Following the acquisition of the parent Itera Group by Rosneft in 2013, the company's alternative energy and biofuel projects were largely discontinued or absorbed into broader state energy initiatives. The company represents an early attempt by the Russian energy sector to diversify into industrial biotechnology and renewable fuels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Itera Ethanol.